Venzyme.LIFE has reviewed your presentation and has the following recommendations.
To evaluate the attractiveness of your venture as an investment, investors need a complete set of critical information. There are a number of "holes" in the materials you have shared that make it difficult for investors to respond favorably. These are:
Company Locations: Useful
Potential Exit Structure: Supplemental
Potential Exit Participants: Supplemental
Outstanding Shares: Supplemental
Pre-Money Valuation: Supplemental
TAM Market Portion (Top down): Useful
SAM: Supplemental